Type A botulinum toxin in the upper aspect of the face

The use of botulinum toxin type A (BTX-A) for facial rejuvenation was first systematically developed by Carruthers and Carruthers on the upper aspect of the face.[1 and 2] In the early 1990s, the first studies of the cosmetic use of BTX-A were published.